CClinicalTrials.gg
CompletedNCT07616596GAZE-CSUpdated Sep 10, 2026

Gaze Stabilization vs Oculomotor Exercises on Cybersickness in Computer Users

An interventional study of Gaze Stabilization Exercises and Oculomotor Exercises in Cybersickness, Motion Sickness and Vestibular Diseases, sponsored by University of Faisalabad. Completed at 1 site in Pakistan. Open to participants aged 18 Years to 45 Years. Per ClinicalTrials.gov, last updated 2026-09-10.

Sponsored by University of Faisalabad · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Many people who use computers for long hours experience "cybersickness" (dizziness, nausea, blurred vision) because their eyes see movement on the screen but their body feels still. This study aims to see which type of eye and head exercises works best to fix this. We will compare Gaze Stabilization Exercises (head movements) against Oculomotor Exercises (eye movements). Forty-six computer users will perform these exercises for 4 weeks. We will measure their dizziness, vision, and quality of life before, during, and after the treatment.

Read the detailed description

This is a single-blinded, randomized clinical trial. Participants (n=46) will be recruited from The University of Faisalabad. Inclusion criteria include screen time >6 hours/day, computer usage for at least 10 years, and a Simulator Sickness Questionnaire (SSQ) score between 20 and 40.

Group A (Intervention): Gaze Stabilization Exercises. Week 1: View X1 exercises. Week 2: View X2 exercises. Week 3: Gaze shift exercises. Week 4: Imaginary Target exercises. (3 sessions/week, 1 minute per exercise, 3 times each).

Group B (Active Comparator): Oculomotor Exercises. Week 1: Range exercises. Week 2: Saccadic exercises. Week 3: Pursuit exercises. Week 4: Vergence exercises. (3 sessions/week, 1 minute per exercise, 3 times each).

Outcomes: The primary outcome is the change in Dynamic Visual Acuity (LogMAR scale) and Cybersickness (SSQ score). The secondary outcome is Quality of Life (SF-36 questionnaire). Measurements will be taken at baseline, Week 2, and Week 4. Data will be analyzed using SPSS version 20.

02

Conditions studied

  • Cybersickness
  • Motion Sickness
  • Vestibular Diseases

Keywords

  • Gaze Stabilization Exercises
  • Oculomotor Exercises
  • Computer Users
  • Vestibulo-Ocular Reflex
  • Dynamic Visual Acuity
  • Physical Therapy
03

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Screen time > 6 hours per day
  • Computer usage history of at least 10 years
  • Complaints of vertigo, blurred vision, and nausea during computer usage
  • Positive Romberg's test
  • Abnormal VOR (4-6 lines lost on LogMAR scale)
  • SSQ score between 20 and 40

Exclusion criteria

Exclusion Criteria:

  • Diagnosed vestibular disorders (e.g., BPPV, Meniere's)
  • History of falls in the past 6 months
  • Pregnancy
  • Any neurological or neurodegenerative disease
  • Use of walking aids
  • Severe visual impairments (worse than 6/12 on Snellen)
04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    Gaze Stabilization Exercises

    Participants in this arm will receive Gaze Stabilization Exercises (GSE) for 4 weeks, 3 sessions per week. The protocol includes View X1, View X2, Gaze Shift, and Imaginary Target exercises. Each exercise is performed for 1 minute, repeated 3 times per session. Exercises target the vestibulo-ocular reflex (VOR) by coordinating head and eye movements to reduce sensory conflict.

    Behavioral: Gaze Stabilization Exercises

  • Active comparator
    Oculomotor Exercises Group

    Participants in this arm will receive Oculomotor Exercises for 4 weeks, 3 sessions per week. The protocol includes Range, Saccadic, Pursuit, and Vergence exercises. Each exercise is performed for 1 minute, repeated 3 times per session. Exercises target isolated eye movements without head motion to improve oculomotor control and reduce visual strain.

    Behavioral: Oculomotor Exercises

Interventions

  • BehavioralGaze Stabilization Exercises

    Week 1 - View X1: Patient sits upright. Target held at eye level 1 meter away. Patient turns head horizontally (left/right) or vertically (up/down) while keeping eyes fixed on target. Speed: slow (1Hz). Duration: 1 minute. Repetitions: 3 times per direction. Week 2 - View X2: Same as View X1 but head movement speed increased to 2Hz. Week 3 - Gaze Shift: Two targets placed 30 cm apart horizontally or vertically. Patient rotates head to face Target 1, then shifts gaze to Target 2 while continuing head rotation toward Target 2. Duration: 1 minute. Repetitions: 3 times. Week 4 - Imaginary Target: Patient fixates on a target (e.g., a sticker on wall). Closes eyes. Rotates head 30-45 degrees away from target. While eyes closed, patient imagines still looking at target. Opens eyes and checks if fixation is accurate. Duration: 1 minute. Repetitions: 3 times per direction. All exercises are performed under supervision for the first 3 sessions, then home-based with weekly follow-up calls.

  • BehavioralOculomotor Exercises

    Week 1 - Range Oculomotor Exercises: Eyes closed. Patient moves eyes slowly in horizontal (left-right), vertical (up-down), diagonal (top-left to bottom-right), and rotational (clockwise/counterclockwise) directions. Duration: 1 minute per direction. Repetitions: 3 times. Week 2 - Saccadic Exercises: Two stationary targets (e.g., two fingers) held 30 cm apart at eye level. Patient rapidly shifts gaze between targets without moving head. Duration: 1 minute. Repetitions: 3 times. Week 3 - Pursuit Exercises: A single target (e.g., pen) is moved slowly horizontally and vertically. Patient follows target smoothly with eyes only (head still). Speed: approx 20 degrees/second. Duration: 1 minute per direction. Repetitions: 3 times. Week 4 - Vergence Exercises: Target (e.g., pen) starts at 50 cm from patient's nose. Patient focuses on target as it is slowly moved toward nose to 5 cm (convergence), then back to 50 cm (divergence). Duration: 1 minute. Repetitions: 3 times under supervision.

05

What researchers measure

Primary outcomes

  1. Change in Vestibulo-Ocular Reflex (VOR) Function

    Measured by Dynamic Visual Acuity (DVA) test using a LogMAR chart. Patient reads smallest line possible while head is stationary (static VA). Then patient rotates head horizontally at 2Hz while reading. Number of lines lost between static and dynamic conditions is recorded. Normal VOR: 1-2 lines lost. Abnormal: 4-6 lines lost. Higher lines lost = worse VOR function.

    Time frame: Baseline (Week 0), Week 2, Week 4

  2. Change in Cybersickness Severity

    Measured by the Simulator Sickness Questionnaire (SSQ). Contains 16 symptoms rated 0-3 (0=not at all, 3=severe). Total score range 0-48. Subscales: Nausea (symptoms 1,2,6,7,8,9,14,15), Oculomotor (3,4,5,10,11,12,13), and Disorientation (5,10,11,12,13,14,15). Higher score = worse cybersickness.

    Time frame: Baseline (Week 0), Week 2, Week 4

Secondary outcomes

  1. Change in Quality of Life

    Measured by the Short Form-36 (SF-36) Health Survey. Contains 36 items measuring 8 domains: Physical Functioning, Role Physical, Bodily Pain, General Health, Vitality, Social Functioning, Role Emotional, Mental Health. Scores transformed to 0-100 scale per domain. Higher score = better quality of life.

    Time frame: Baseline (Week 0), Week 4

06

Study locations

1 site
  • The University of Faisalabad
    Faisalābad, Punjab Province 3800, Pakistan
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT07616596
Lead sponsor
University of Faisalabad
Responsible party
Dr. Marium Zafar (Associate Professor/ Head, Department of Rehabilitation Sciences, University of Faisalabad) — Principal investigator
First posted
Jun 1, 2026
Start date
Jan 1, 2026
Primary completion
May 10, 2026
Completion
Jun 22, 2026
Last update
Sep 10, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion